ID   B16-BL6
AC   CVCL_0157
SY   B16/BL6; B16 BL6; B16BL6; B16BL-6; BL6; BL-6; B16-F10-BL6
DR   BTO; BTO_0002808
DR   CLO; CLO_0050759
DR   MCCL; MCC:0000049
DR   ChEMBL-Cells; CHEMBL4295415
DR   ChEMBL-Targets; CHEMBL4296400
DR   KCLB; 80006
DR   NCI-DTP; B16BL-6
DR   PubChem_Cell_line; CVCL_0157
DR   RCB; RCB2638
DR   TKG; TKG 0598
DR   Wikidata; Q54752412
RX   PubMed=2297053;
RX   PubMed=3370643;
RX   PubMed=7370995;
RX   PubMed=11833741;
CC   Characteristics: Highly invasive.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0159 ! B16-F10
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
RX   PubMed=2297053; PMCID=PMC1877453;
RA   Schackert G., Price J.E., Zhang R.-D., Bucana C.D., Itoh K.,
RA   Fidler I.J.;
RT   "Regional growth of different human melanomas as metastases in the
RT   brain of nude mice.";
RL   Am. J. Pathol. 136:95-102(1990).
//
RX   PubMed=3370643;
RA   Schackert G., Fidler I.J.;
RT   "Site-specific metastasis of mouse melanomas and a fibrosarcoma in the
RT   brain or meninges of syngeneic animals.";
RL   Cancer Res. 48:3478-3484(1988).
//
RX   PubMed=7370995;
RA   Poste G., Doll J., Hart I.R., Fidler I.J.;
RT   "In vitro selection of murine B16 melanoma variants with enhanced
RT   tissue-invasive properties.";
RL   Cancer Res. 40:1636-1644(1980).
//
RX   PubMed=11833741; DOI=10.1016/S0024-3205(01)01454-0;
RA   Nakamura K., Yoshikawa N., Yamaguchi Y., Kagota S., Shinozuka K.,
RA   Kunitomo M.;
RT   "Characterization of mouse melanoma cell lines by their mortal
RT   malignancy using an experimental metastatic model.";
RL   Life Sci. 70:791-798(2002).
//